Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Capital Expenditures (2010 - 2026)

Exelixis (EXEL) posted quarterly Capital Expenditures of $1.5 million for Q2 2026, down 48.88% year-over-year from $3.0 million in Q2 2025, and up 30.42% quarter-over-quarter from $1.2 million in Q1 2026.

Analysis

Exelixis (EXEL) Capital Expenditures (2010 - 2026) Analysis & Trends

Exelixis' Capital Expenditures history runs 17 years deep, the most recent figure standing at $1.5 million for Q2 2026.

  • In Q2 2026, Capital Expenditures fell 48.88% year-over-year to $1.5 million; the TTM figure through Apr 2026 stood at $7.0 million (down 67.8% YoY), while the FY2026 annual figure was $8.4 million, down 70.36% from the prior year.
  • Capital Expenditures for Q2 2026 stood at $1.5 million, up from $1.2 million in the prior quarter.
  • The five-year high for Capital Expenditures was $13.1 million in Q4 2023, with the low at $1.2 million in Q1 2026.
  • The 5-year median for Capital Expenditures is $5.9 million (2023), against an average of $6.3 million.
  • The sharpest annual moves came in 2022 and 2025: Capital Expenditures surged 117.62% in 2022, then plunged 81.92% in 2025.
  • Exelixis' Capital Expenditures stood at $9.7 million in 2022, then surged by 35.18% to $13.1 million in 2023, then sank by 37.59% to $8.2 million in 2024, then slumped by 81.92% to $1.5 million in 2025, then rose by 1.82% to $1.5 million in 2026.
  • Business Quant data shows EXEL's Capital Expenditures at $1.5 million in Q2 2026, $1.2 million in Q1 2026, and $1.5 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 112.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 240.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 37.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 2.29 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 25.02 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 34.68 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 251.02 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.26 Mn
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn 6.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 6.82 Mn
Apr 3, 2026 1.51 Mn
Jan 2, 2026 1.16 Mn
Oct 3, 2025 1.48 Mn
Jul 4, 2025 2.84 Mn
Apr 4, 2025 2.95 Mn
Jan 3, 2025 3.98 Mn
Sep 27, 2024 8.20 Mn
Jun 28, 2024 6.57 Mn
Mar 29, 2024 9.69 Mn
Dec 29, 2023 13.14 Mn
Sep 29, 2023 9.37 Mn
Jun 30, 2023 5.94 Mn
Mar 31, 2023 12.02 Mn
Dec 30, 2022 9.72 Mn
Sep 30, 2022 5.04 Mn
Jul 1, 2022 7.34 Mn
Apr 1, 2022 5.61 Mn
Dec 31, 2021 5.96 Mn
Oct 1, 2021 14.50 Mn